Genentech Licenses Alector Brain Delivered GCase
Genentech licensed worldwide rights to Alector’s preclinical AL050 program for $100 million upfront, as much as $1.17 billion in conditional milestones and tiered royalties. AL050 couples engineered GCase to a blood-brain-barrier carrier. The agreement…
